The Sinopharm candidates will be tested as boosters in adults who have already received two or three vaccine doses
The Australian biotechnology company and its peers have been fighting a ruling that banned Mexican citizens from entering the US to donate plasma.
The biotech firm's shares were trading up 7% by mid-session, their biggest intraday gain since March 2020
Shares plunged nearly 20% on Wednesday after a report that Washington was considering blacklisting Chinese biotechnology groups
Health and tech firms tumbled after an FT report that the US will add eight more Chinese firms, including DJI, the large commercial drone maker, and biotech firms, to government blacklists
Kunming-based company to expand its pneumonia vaccine production capacity with an investment of 695 million yuan ($109m)
Long-anticipated commercialisation of GM corn in the world's No. 2 producer is set to significantly boost yields, reducing the need for imports, firm claims
Company obtained a $360 million grant from the Coalition for Epidemic Preparedness Innovations, the disease research funding group, and its launch customer will be the Global Vaccine Alliance
(ATF) The coronavirus vaccine developed by China’s Sinovac Biotech showed a general efficacy of less than 60% in...